Assenagon Asset Management’s NeoGenomics NEO Stock Holding History

Assenagon Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,611,674	Closed	-$29.4M	–	1474
2022 Q2	$29.4M	Buy	3,611,674 +3,551,602	+5,912%	+$33.9M	0.11%	179
2022 Q1	$730K	Buy	+60,072	New	+$1.26M	﹤0.01%	1133
2021 Q4	–	Sell	-4,998	Closed	-$241K	–	1510
2021 Q3	$241K	Buy	+4,998	New	+$231K	﹤0.01%	1203
2020 Q4	–	Sell	-29,143	Closed	-$1.07M	–	1179
2020 Q3	$1.07M	Buy	+29,143	New	+$1.08M	0.01%	778
2019 Q1	–	Sell	-28,162	Closed	-$355K	–	1053
2018 Q4	$355K	Buy	+28,162	New	+$420K	﹤0.01%	892

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Assenagon Asset Management's NEO Position: Q3 2022 in Review

Assenagon Asset Management sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 3,611,674 shares — an estimated $29.4M sold.

Assenagon Asset Management first reported a position in NEO in Q4 2018 and held it in 5 quarters. The position peaked at $29.4M in Q2 2022. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

Assenagon Asset Management reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
Assenagon Asset Management sold 3,611,674 NeoGenomics shares in Q3 2022, an estimated $29.4M.
Assenagon Asset Management first reported a position in NeoGenomics in Q4 2018 and held it in 5 quarters.
Assenagon Asset Management's NeoGenomics position peaked at $29.4M in Q2 2022.
245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Assenagon Asset Management's 13F filing for Q3 2022, filed 27 Oct 2022.